

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Charles Hatt, lawyer, Ecojustice
416 368 7533 x 524 | chatt@ecojustice.ca
Anne Bell, Director of Conservation and Education, Ontario Nature
416 444 8419 x 239 (o) | 416-659-2339 (c) | anneb@ontarionature.org
Dr. Faisal Moola, PhD, Director General, Ontario and Northern Canada, David Suzuki Foundation
647 993 5788 (c)
Beatrice Olivastri, Chief Executive Officer, Friends of the Earth Canada
613 724 8690 (c) | beatrice@foecanada.org
Gwen Barlee, National Policy Director, Wilderness Committee
604-202-0322 (c) | gbarlee@gmail.com
Environmental groups are headed to court in a bid to protect pollinators from a harmful class of pesticides.
The David Suzuki Foundation, Friends of the Earth Canada, Ontario Nature and the Wilderness Committee have been tracking the scientific evidence linking neonicotinoid pesticides and pollinator deaths. Now, they say it's time for Canada to stop ignoring the risks.
Ecojustice lawyers representing the groups argue that a number of pesticides containing two neonicotinoid active ingredients (Clothianidin and Thiamethoxam) are unlawfully registered in Canada.
They allege that the Pest Management Regulatory Agency (PMRA) failed to live up to its legal responsibilities as a regulator. Specifically, the Agency failed to ensure for more than a decade that it had the scientific information necessary to determine the pesticides' environmental risks, in particular risks to pollinators. The federal Pest Control Products Act requires the PMRA have "reasonable certainty" that a pesticide will cause no harm to the environment before registering it.
They also point to a number of Thiamethoxam-based pesticides that have been registered for years in Canada without ever being subject to public consultation required by the Act.
The environmental groups are asking the court to declare the registrations of these Clothianidin and Thiamethoxam-based pesticides invalid. Only validly registered pesticides can be used in Canada.
Ecojustice lawyer, Charles Hatt, said: "The PMRA has taken a see-no-evil, hear-no-evil, speak-no-evil approach by repeatedly registering these neonicotinoid pesticides without important scientific information on their risks to pollinators."
Anne Bell, Director of Conservation and Education at Ontario Nature, said: "Pollinators are key players in our ecosystems, and their declines are extremely concerning. A stunning variety of plants -- including fruits, vegetables, nuts, and 90 per cent of flowering plants -- need pollinators to reproduce and thrive."
Gwen Barlee, National Policy Director at the Wilderness Committee, said: "Pollinator populations are plummeting and the science tells us that neonicotinoids play a big role in that decline. So why is the PMRA continuing to allow their use and sale? We need to get these bee-killing pesticides out of Canadian agriculture."
Beatrice Olivastri, Chief Executive Officer at Friends of the Earth, said: "Decision-makers in the European Union, France, and even Ontario have already opted to heavily restrict the use of neonicotinoids. It's time for Canada to join this push to protect pollinators."
Dr. Faisal Moola, PhD, Director General of Ontario and Northern Canada at the David Suzuki Foundation, said: "The Province of Ontario recently brought in strong restrictions on the use of dangerous neonicotinoid pesticides in agriculture. We're hoping that our court case will compel the federal government to take similar action in response to widespread public concern over the fate of pollinators in Canada."
About neonicotinoids:
As Canada's only national environmental law charity, Ecojustice is building the case for a better earth.
"We cannot afford to sit by while our NHS is picked apart by a foreign regime," said one member of Parliament.
One member of British Parliament called on the Labour government to defend the country's revered National Health Service "with everything we have and firmly stand up to the bully in the White House" after a study published Wednesday showed the UK-US pharmaceutical trade deal brokered last year is projected to cause 229,000 excess deaths as funding is stripped away from the NHS.
“It is a complete insult to patients who are suffering and dying on hospital trolleys and waiting months for treatment," said Helen Morgan of the Liberal Democrats Party regarding the new analysis. "We cannot afford to sit by while our NHS is picked apart by a foreign regime."
The study, conducted by researchers at the University of York, the University of Liverpool, and Christchurch Hospital in New Zealand and published in the British Medical Journal, found that £44.7 billion ($59.5 billion) will have to be diverted from health services by 2036 in order to pay for new medications under the deal.
The agreement was reached last December, with recently resigned Prime Minister Keir Starmer's government agreeing to pay 25% more for new US medications over the next decade. The NHS will double the percentage of gross domestic product that it allocates for pharmaceuticals, from 0.3% to 0.6%, with the spending increasing from 10% to 12% of the universal healthcare system's budget.
In exchange, the Trump administration agreed not to impose tariffs of up to 100% that he had threatened for UK medicines being imported to the US.
Science Minister Patrick Vallance insisted in April that the deal would give NHS patients access to "life-changing new medicines that they previously would have been denied" while boosting the UK's "life sciences sector" by avoiding Trump's tariffs.
"Scandalously, this backroom deal was not subject to any scrutiny in Parliament before being rushed through—and the government refuses to say what impact it will have on the NHS."
But Sir Ciarán Devane, chief executive of the NHS Alliance, told The Guardian that the study raised "serious questions" about whether Britons will truly benefit from the agreement.
"If billions of pounds are diverted away from frontline care to meet higher medicines costs, the consequences for prevention, community services, and the treatment of long-term conditions could be profound," said Devane. "The government must urgently publish the full impact assessment and ensure there is appropriate scrutiny of the deal if it could have such far-reaching implications for population health.”
The projected avoidable death toll in the study far exceeds that which the UK saw during the coronavirus pandemic, when 137,000 excess deaths were recorded between March 2020-June 2022.
"If the indirect effect on adult social care is also included, the increase in excess deaths is even greater (291,000),” reads the study.
The greatest number of excess deaths is projected to occur in patients suffering from cardiovascular, respiratory, and gastrointestinal issues as well as cancer.
Patients with “neurological, endocrine, musculoskeletal, and mental health problems" will also face "broader effects on quality of life," the research states.
The government has assured the public that "frontline services" will be protected, notes the report, but "the NHS will need to fund this deal from allocations made six months before the deal was agreed. The evidence suggests that if additional public expenditure was available, it could be more effectively deployed within the NHS itself."
The research projected that the greatest number of deaths would occur in cardiovascular, respiratory, gastrointestinal and cancer patients.
It added that there will also be broader harm caused to quality of life for patients in those sectors as well as “neurological, endocrine, musculoskeletal, and mental health problems”.
Tim Bierley, a campaigner with the UK-based group Global Justice Now, said that the report "adds to the overwhelming evidence that the Trump medicines deal risks taking a wrecking ball to our health and our economy."
"Billions that could be spent on recruiting more NHS staff, cutting [general practitioner] waiting times, or improving our hospital care are set to be siphoned off by corporate giants in the pharma industry," said Bierley, whose group has joined the campaign Just Treatment in filing a legal challenge against the deal. "Scandalously, this backroom deal was not subject to any scrutiny in Parliament before being rushed through—and the government refuses to say what impact it will have on the NHS."
"The next prime minister," said Bierley, "must change direction, stand up for our NHS, and unpick the mess left by their predecessors.”
Those arrested in the recent surge include a 56-year-old Catholic nun from Nigeria.
Ordered by the Trump White House to aggressively increase arrest rates, federal immigration officials have reportedly detained more than 10,000 people in just the last five days, intensifying fear in communities across the United States.
The New York Times, which was first to report the new detention figures late Wednesday, noted that Immigration and Customs Enforcement (ICE) officials were "told that 2,000 arrests a day was the new standard for enforcement." The agency, flush with cash following President Donald Trump's signing of a reconciliation package containing another $70 billion for immigration enforcement, has been instructed to assign 80% of its officers to "arrest operations," according to the Times.
The Trump administration claims to be targeting the "worst of the worst," but available data shows that the percentage of people arrested by ICE despite having no criminal convictions has tended to rise during the agency's mass detention efforts. On Sunday, ICE briefly detained a 56-year-old nun from Nigeria as she walked to church in McAllen, Texas.
"The geniuses at ICE just arrested a Catholic nun, who practices as a nurse, as she was walking to church," Sen. Sheldon Whitehouse (D-RI) wrote in response to Sister Leticia Ugboaja's detention. "Our Republican colleagues think they need even more money. Had enough?"
The Times reported that immigration attorneys across the US "have been on alert" as ICE arrests surge, though much more quietly than earlier blitzes in Minneapolis—where federal immigration agents killed two US citizens—and other major cities, where groups of armed and masked officers roamed the streets and menaced neighborhoods.
"Cindy Blandon, an immigration attorney in Miami, said that one of her clients, a Nicaraguan father of two children, had an immigration court hearing set for 2027, but was arrested by ICE on Monday during a routine check-in," the Times reported. "And in Utah, Ysabel Lonazco, an immigration attorney, has noticed an uptick as well... One of her clients, Arturo, a 48-year-old Mexican man, was arrested in Salt Lake City on his way to a soccer game on Sunday, according to his wife, Veronica. She said the arrest had shattered their family."
ICE also appears to be ignoring a federal judge's order last week curtailing arrests at immigration courthouses. According to The Intercept:
On Thursday, U.S. Immigration and Customs Enforcement agents arrested an Ecuadorian man at a court at 26 Federal Plaza and a man from the Dominican Republic at another court at 290 Broadway, both in Lower Manhattan. The arrests continued on Monday, when ICE agents detained a third man, originally from Guatemala, at 290 Broadway.
In legal filings challenging the detentions of the men taken Thursday, advocates with the nonprofit Make the Road New York accused ICE of not only violating their clients’ right to due process, but also of brazenly flouting a federal court order.
Murad Awawdeh, president and CEO of the New York Immigration Coalition, told The Intercept that "we’re witnessing ICE, yet again, operate in a lawless and rogue fashion and not following court orders."
“We’re supposedly a nation under the rule of law, and our judicial branch has said that this agency must stop engaging in this lawless behavior, and they continue to do so," said Awawdeh.
ICE is currently headed by Acting Director David Venturella, a former private prison executive. A record number of people have died in ICE custody under the second Trump administration.
Last week, Trump announced that he intends to nominate former Oklahoma state trooper Lance Schroyer to lead ICE in a permanent capacity.
Marcos Charles, the head of ICE’s deportation wing, cheered the recent arrest surge in an email to agency personnel earlier this week. On Saturday, ICE officers arrested 2,400 people.
“I want to personally thank each of you for your extraordinary efforts this past weekend,” Charles wrote, according to the Times. “Through your dedication, professionalism, and unwavering commitment to our mission, enforcement and removal operations achieved remarkable operational results."
Environmental and public health advocates on Wednesday ripped the US Environmental Protection Agency's fifth approval of a "forever chemical" pesticide during the current term of President Donald Trump, who campaigned on a promise to "Make America Healthy Again."
Despite that pledge, Trump's second administration—much like his first—has served the pesticide industry in various ways, including by putting out a MAHA report that echoes industry talking points, installing a former industry lobbyist in a key EPA post, backing Bayer-owned Monsanto over cancer patients at the US Supreme Court, and issuing an executive order that mandates the production of glyphosate.
Under Trump, the EPA has also approved or reapproved various controversial pesticides, from atrazine and dicamba to trifludimoxazin, which was approved late Tuesday. Like diflufenican and epyrifenacil, which were authorized by the EPA earlier Tuesday, as well as cyclobutrifluram and isocycloseram, which got a green light from the agency last November, trifludimoxazin is what some scientists and campaigners call a forever chemical pesticide.
Per- and polyfluoroalkyl substances (PFAS)—which have been used in not only pesticides but also fabrics, firefighting foam, nonstick cookware, and other household products—are widely known as forever chemicals because they don't break down naturally. They're also linked to a range of health issues, including various cancers.
"This is the PFAS presidency brought to you by Donald Trump and EPA Administrator Lee Zeldin," Nathan Donley, environmental health science director at the Center for Biological Diversity, declared Wednesday.
As with his Tuesday critique of the Trump EPA approving diflufenican and epyrifenacil, Donley pointed to the Supreme Court's recent ruling in favor of Trump-backed Bayer, rather than the thousands of Americans who argue that Monsanto's glyphosate-based weedkiller Roundup caused their cancer.
"Waiting to open the floodgates on new pesticide approvals until after the Supreme Court granted immunity to pesticide companies takes a special kind of callousness," he said.
Bill Freese, science director at Center for Food Safety (CFS), similarly said Wednesday that "with yesterday's pesticide approvals, the Trump administration's EPA is once again showing its disdain for Americans' health and the natural world."
"The EPA's pesticide division is seemingly no longer able to recognize evidence that a pesticide causes cancer, even when it's the pesticide company's own studies that show it," he continued. "And as per usual, EPA dismisses out of hand incriminating independent studies by scientists not affiliated with the pesticide industry."
In addition to the PFAS pesticides, the EPA is under fire this week for approving new uses for chlormequat, a non-PFAS pesticide tied to reproductive issues, and the fungicide fluoxapiprolin.
CFS co-executive director Sylvia Wu pointed out that the agency dismissed studies showing that fluoxapiprolin and epyrifenacil both produce tumors in laboratory rodents and classified both as "not likely to be carcinogenic to humans."
"The EPA's illegitimate rejection of the evidence that these two pesticides cause cancer is very similar to the tricks it pulled in denying glyphosate could cause cancer," Wu said. "These blatant violations of the agency's own cancer guidelines are unacceptable."
As for chlormequat, Freese said that "EPA should never have approved this endocrine-disrupting pesticide, particularly since its persistence and potential for widespread use on wheat and other widely consumed grains will mean universal exposure."
Already, "chlormequat is found in the urine of 90% of Americans, thought to come mostly from residues on imported foods where the pesticide has been used," the Center for Biological Diversity noted Wednesday. Like Freese, the group warned that "approval of its use on US wheat and oats ensures that exposure to the US population will increase dramatically."